Listed

Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2018

Filed with the SEC on Nov 14, 2018 and accepted by EDGAR at Nov 14, 2018, 16:37 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-07-01 to 2018-09-30$52.4kus-gaap:Revenues
Revenue9 months2018-01-01 to 2018-09-30$66.8kus-gaap:Revenues
Cost of revenue3 months2018-07-01 to 2018-09-30$36.4kus-gaap:CostOfRevenue
Cost of revenue9 months2018-01-01 to 2018-09-30$41.3kus-gaap:CostOfRevenue
Gross profit3 months2018-07-01 to 2018-09-30$16.0kus-gaap:GrossProfit
Gross profit9 months2018-01-01 to 2018-09-30$25.5kus-gaap:GrossProfit
Research and development3 months2018-07-01 to 2018-09-30$2.9kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2018-01-01 to 2018-09-30$10.3kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-07-01 to 2018-09-30−$274.8kus-gaap:OperatingIncomeLoss
Operating income9 months2018-01-01 to 2018-09-30−$793.9kus-gaap:OperatingIncomeLoss
Interest expense3 months2018-07-01 to 2018-09-30$377.0kus-gaap:InterestExpense
Interest expense9 months2018-01-01 to 2018-09-30$981.3kus-gaap:InterestExpense
Net income3 months2018-07-01 to 2018-09-30−$1.6mus-gaap:NetIncomeLoss
Net income9 months2018-01-01 to 2018-09-30−$15.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-07-01 to 2018-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2018-01-01 to 2018-09-30−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2018-01-01 to 2018-09-30−$756.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2018-09-30$172.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-09-30$186.8kus-gaap:AssetsCurrent
Total assetsAt period end2018-09-30$355.6kus-gaap:Assets
Current liabilitiesAt period end2018-09-30$7.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-09-30$7.7mus-gaap:Liabilities
Long-term debtAt period end2018-09-30$987.8kus-gaap:LongTermDebt
Shareholders' equityAt period end2018-09-30−$7.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-18-059990. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.